Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag FDA proposes restricting compounding of weight-loss drugs to curb generic versions.

flag The FDA has proposed removing ingredients for popular weight-loss drugs from a list that allows pharmacies to compound them, aiming to restrict large-scale production of generic-like versions. flag This move is expected to lower the availability of cheaper alternatives, though most personalized compounding may remain unaffected. flag The agency is accepting public comments on the proposal until June 29.

7 Articles